Project led by RI-MUHC researchers wins award at Oncopole's Priorité patient Competition
New grant supports integration of peer support and counselling ...
Understanding the psychological trauma related to facial transplantation
Dr. Mirko Gilardino is co-author of study that examines issues around patients’ consent
Supporting those grieving requires “literacy,” researcher Mary Ellen Macdonald suggests
Grief amidst the pandemic is an increasing reality in communities worldwide
Protecting lung cancer patients from COVID-19 – and learning from the experience
A study led by Dr. Nathaniel Bourganim tracked changes in treatment plans
Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19
Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations
The World Brain Death Project: New publication offers significant and unprecedented consensus on the question of when brain death occurs
Dr. Sam Shemie offers a reference standard for practices worldwide
Canada Research Chairs Program announces new and renewed chairs
Congratulations to five RI-MUHC researchers in the spring 2020 round!
Dr. Thomas Emmett Francoeur awarded the Prix Letondal
Pioneering work in child development recognized by the Association of Pediatricians of Quebec
At the heart of precision medicine
New translational collaboration aims to transform approach to heart muscle disease
COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study
Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality